More on PPHM by Lynnai
Latest PPHM Transcript
-
Peregrine Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript
Tue, Mar 12
Latest PPHM Articles
-
Peregrine Pharmaceuticals, The Little Biotech With The Golden Goose Of Immunotherapy
Thu, May 23 • Chris Lacoursiere
-
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Fri, May 3 • Life Sciences Report
-
Threshold: My Biotech Pick Of The Year
Tue, Apr 23 • Equity Options Guru
-
Follow The Crashing Biotechs: 4 Stocks Fresh From A Fall
Wed, Mar 20 • Craig Keolanui
-
Peregrine Releases Earnings, But The Situation Remains The Same
Wed, Mar 13 • Brian L. Wilson
-
Peregrine's Bavituximab Future Looks Bleak
Tue, Mar 12 • Chimera Research Group
-
Why These 4 Biotechs Could Be Next In Line To See Their Share Prices Rise
Fri, Mar 8 • Vineet Dutta
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
Peregrine Pharmaceuticals Inc. (PPHM)
Posts on PPHM by Lynnai
LSCC, PSUN, CAE, PPHM Stock-PR.com Report!
Posts on PPHM by other instabloggers
-
Thu, May 2
•
Life Sciences Report
-
Tue, Apr 30
•
TipRanks
-
Thu, Mar 7
•
Life Sciences Report
-
Wed, Feb 13
•
MissionIR
-
Thu, Jan 31
•
Life Sciences Report
All instablog posts on PPHM »Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Worst Recommendation Of 2013 – 80% Loss
10 Biotech Stocks Poised To Run: George Zavoico
Peregrine Pharmaceuticals, Inc. (PPHM) Reveals Results From Phase II Clinical Trial Of Bavituximab
The Life Sciences Report Watchlist 2013